Study of Glycemic Variability, Hypoglycemia Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Changed from Basal-Bolus Therapy to Basal-GLP-1 RA Therapy

Study of Glycemic Variability, Hypoglycemia Using Continuous Glucose Monitoring in Type 2 Diabetes Mellitus Changed from Basal-Bolus Therapy to Basal-GLP-1 RA Therapy - From BBT To BGT Study in T2DM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046200

Enrollment

Registered

2021-12-01

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients who are receiving multiple daily insulin injection therapy, have HbA1c or fasting blood glucose / postplandial blood glucose levels within the control target, and have insulin endocrine ability remaining.

Exclusion criteria

Exclusion criteria: Diabetic patients with poor glycemic control due to multiple daily insulin injection therapy

Design outcomes

Primary

Measure	Time frame
Changes in HbA1c and patient satisfaction immediately before switching from BBT to BGT and 1 month after switching	—

Countries

Japan

Contacts

Public ContactArina Miyoshi

Sapporo City General Hospital Department of Diabetes and Endocrinology

a.miyoshi@hotmail.co.jp0117262211

Outcome results